Press release

Peter Rossing, MD, DMSc, Receives the American Diabetes Association’s® 2019 Edwin Bierman Award

May 30, 2019 | Arlington, Virginia

Peter Rossing, MD, DMSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Edwin Bierman Award. This award recognizes a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors. Dr. Rossing will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver his Edwin Bierman Award Lecture, titled “Linking Kidney and Cardiovascular Complications—Impact on Prognosis and Treatment,” on Monday, June 10.

Currently Head of Complications Research and Chief Physician at Steno Diabetes Center in Copenhagen, Denmark, Dr. Rossing is a pioneer and renowned expert who has made lasting impacts within the areas of diabetes and macrovascular complications. With more than 390 articles in prestigious journals, Dr. Rossing’s research addressing the renal and cardiovascular complications of diabetes has been acknowledged internationally. His work investigated key features of the pathophysiology of the diabetic kidney, as well as identified markers for the development of diabetic nephropathy.

“I would like to congratulate Dr. Rossing on this achievement, and thank him for his significant contributions to our understanding of diabetes-related vascular complications and risk factors,” said the ADA’s 2019 President of Medicine and Science Louis H. Philipson, MD, PhD, FACP. “He has worked diligently to improve the prognosis of patients with overt diabetic nephropathy.”

Dr. Rossing’s research on macrovascular diseases was recently brought to the forefront in the American Diabetes Association-European Association for the Study of Diabetes (EASD) joint position statement, Management of Hyperglycemia in Type 2 Diabetes. Furthermore, he has served in leadership roles including Past President of the Danish Endocrine Society and European Diabetic Nephropathy Study Group, and received two awards presented by the EASD.

The American Diabetes Association’s 79th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention and care, will be held June 7-11, 2019, at the Moscone Center in San Francisco, California. Nearly 15,000 leading physicians, scientists, health care professionals and industry representatives from around the world are expected to convene at the Scientific Sessions to unveil cutting-edge research, treatment recommendations and advances toward a cure for diabetes. During the five-day meeting, attendees will receive exclusive access to more than 850 presentations and 2,000 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight thematic areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Gretchen Youssef, MS, RDN, CDE, President of Health Care and Education, will deliver her address, “It’s All about Access!,” on Saturday, June 8, and Louis H. Philipson, MD, PhD, FACP, President of Medicine and Science, will deliver his lecture, “Precision Medicine—Addressing the Many Faces of Diabetes,” on Sunday, June 9. Join the Scientific Sessions conversation on social media using #ADA2019.

# # #

, About the American Diabetes Association

Every day more than 4,000 people are newly diagnosed with diabetes in America. Nearly 115 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).